(19)
(11) EP 2 908 883 B8

(12) CORRECTED EUROPEAN PATENT SPECIFICATION
Note: Bibliography reflects the latest situation

(15) Correction information:
Corrected version no 1 (W1 B1)

(48) Corrigendum issued on:
06.12.2023 Bulletin 2023/49

(45) Mention of the grant of the patent:
06.09.2023 Bulletin 2023/36

(21) Application number: 13847858.1

(22) Date of filing: 04.10.2013
(51) International Patent Classification (IPC): 
G16H 20/17(2018.01)
A61M 5/142(2006.01)
(52) Cooperative Patent Classification (CPC):
A61M 5/1452; A61M 5/1723; A61M 5/50; A61M 2205/27; A61M 2205/3569; A61M 2205/502; A61M 5/14244; A61M 5/16831; G16H 20/17
(86) International application number:
PCT/US2013/063513
(87) International publication number:
WO 2014/062399 (24.04.2014 Gazette 2014/17)

(54)

INFUSION PUMP SYSTEM AND METHODS

INFUSIONSPUMPENSYSTEM UND -VERFAHREN

SYSTÈME ET MÉTHODES DE POMPE À PERFUSION


(84) Designated Contracting States:
AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR

(30) Priority: 16.10.2012 US 201213652905

(43) Date of publication of application:
26.08.2015 Bulletin 2015/35

(60) Divisional application:
23194666.6

(73) Proprietor: Insulet Corporation
Acton MA 01720 (US)

(72) Inventor:
  • ESTES, Mark C.
    Malibu, California 90265 (US)

(74) Representative: Peterreins Schley 
Patent- und Rechtsanwälte PartG mbB Hermann-Sack-Straße 3
80331 München
80331 München (DE)


(56) References cited: : 
WO-A1-2014/062399
US-A1- 2008 201 325
US-A1- 2012 259 278
US-B2- 8 029 459
US-A1- 2006 173 406
US-A1- 2010 094 251
US-B2- 7 704 226
   
  • G. SHAPIRA ET AL: "Bolus Guide: A Novel Insulin Bolus Dosing Decision Support Tool Based on Selection of Carbohydrate Ranges", JOURNAL OF DIABETES SCIENCE AND TECHNOLOGY, vol. 4, no. 4, 1 July 2010 (2010-07-01), pages 893-902, XP055223361, US ISSN: 1932-2968, DOI: 10.1177/193229681000400418
   
Note: Within nine months from the publication of the mention of the grant of the European patent, any person may give notice to the European Patent Office of opposition to the European patent granted. Notice of opposition shall be filed in a written reasoned statement. It shall not be deemed to have been filed until the opposition fee has been paid. (Art. 99(1) European Patent Convention).